about
Use of allele-specific FAIRE to determine functional regulatory polymorphism using large-scale genotyping arraysExome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.APOC3, coronary disease, and complexities of Mendelian randomization.HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.Adult-onset liver disease and hepatocellular carcinoma in S-adenosylhomocysteine hydrolase deficiencyFour Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies.Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci.Low-density lipoprotein cholesterol and risk of gallstone disease: a Mendelian randomization study and meta-analyses.Adeno-associated viral vector transduction of human mesenchymal stem cells.Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study.Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver.Relationship between Genetic Variation at PPP1R3B and Liver Glycogen and Triglyceride Levels.Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals.Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study.A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease.Identification and replication of six new loci associated with gallstone diseaseHSD17B13 and Chronic Liver Disease in Blacks and HispanicsSterol transporter adenosine triphosphate-binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general populationGenetic variation in liver X receptor alpha and risk of ischemic vascular disease in the general populationGenetic Variation in NPC1L1 and Risk of Gallstone DiseaseResponse to: liver fat content, non-alcoholic fatty liver disease, and ischaemic heart diseaseAssessment of Rapid Hepatic Glycogen Synthesis in Humans Using Dynamic 13C Magnetic Resonance SpectroscopyCombined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General PopulationHSD17B13 as a promising therapeutic target against chronic liver diseaseHigh Risk of Fatty Liver Disease Amplifies the Alanine Transaminase-Lowering Effect of a HSD17B13 VariantPNPLA3 Genotype and Risk of Liver and All-Cause Mortality
P50
Q34390623-468FAE1E-E67D-4566-8261-7E92BAAB6731Q34404491-03EB7D14-D82F-4B2B-9E86-A81FFE3BCF59Q34532262-39C56FD6-80DA-4FAC-8E5D-6A46191C4D76Q35065253-C3C1C1AF-7534-4AB6-9729-5672290F2E53Q36522782-9772467D-421C-4431-B497-A3E6FD684942Q39839071-E6CF7498-FAED-46B8-A4FB-4E8E75D18CD7Q42347122-2B315469-725A-43F8-A362-3BCB7238D85EQ44631390-362CEAF0-92E2-4246-97EC-35F12E32DC49Q45868527-BE5B64A8-DE9F-432A-ACD6-9C44D44F036AQ46485524-6348BF87-95F6-43ED-A40A-8E523666B7E6Q47245103-DC864F08-8AEE-4693-AC37-EC9263DB2BC3Q47265933-E98999BC-0553-497D-BAAC-6F7EB4317040Q47307583-97906E89-A0FC-40DF-A752-36EF52D7F254Q51607498-0942DF32-8FD5-4079-A3FF-1372755CAC2CQ52644811-6756EFB3-91A8-4048-9282-CB4311DFA860Q57457482-D778B175-7146-4077-B939-A353D2AD74D2Q58586098-0824448E-29E5-4E37-A200-D28F8F061FB8Q83316464-19F05AB1-8972-49AF-8148-B6381EA1090BQ84919932-CF3DE96D-CA33-4AB8-91A3-3ABAEA0E51FBQ86018693-D9B03980-F58B-4EEF-9F68-E799239F4400Q88588535-06C9EBD7-53C2-457F-9FB9-CEAB5FFEE351Q90095560-EE9A533D-6D08-4758-81A1-D881006E4120Q90453072-00771215-4591-49FD-AB89-50D3039F3EF7Q91628442-F05B27F7-AD69-4D36-8946-601D49B0881DQ92473793-EEDCC316-8389-4182-A1A3-534500ABABB2Q92744272-EFF1B21B-B327-40F1-9EE6-AC3C6D75D45F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stefan Stender
@ast
Stefan Stender
@en
Stefan Stender
@es
Stefan Stender
@nl
type
label
Stefan Stender
@ast
Stefan Stender
@en
Stefan Stender
@es
Stefan Stender
@nl
prefLabel
Stefan Stender
@ast
Stefan Stender
@en
Stefan Stender
@es
Stefan Stender
@nl
P106
P108
P21
P31
P496
0000-0003-0281-5900